BioMaxima S.A. (WSE:BMX)
Poland · Delayed Price · Currency is PLN 9.38
-0.11 (-1.16%)
Jul 6, 2026, 5:00 PM CET
BioMaxima Market Cap
BioMaxima has a market cap or net worth of 39.33 million as of July 6, 2026. Its market cap has decreased by -32.52% in one year.
Market Cap
39.33M
Enterprise Value
52.05M
Revenue
60.90M
Ranking
n/a
PE Ratio
374.59
Stock Price
9.38
Market Cap Chart
Since July 21, 2010, BioMaxima's market cap has increased from 11.40M to 39.33M, an increase of 244.90%. That is a compound annual growth rate of 8.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 39.33M | -22.16% |
| Dec 30, 2025 | 50.53M | 12.62% |
| Dec 30, 2024 | 44.87M | -34.84% |
| Dec 29, 2023 | 68.85M | -35.28% |
| Dec 30, 2022 | 106.38M | -6.37% |
| Dec 30, 2021 | 113.62M | -4.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.13B |
| NEUCA | 3.20B |
| Synektik Spólka Akcyjna | 3.08B |
| Voxel | 1.21B |
| Read-Gene | 55.30M |
| Milton Essex Spólka Akcyjna | 50.72M |
| Sygnis | 42.42M |
| Nestmedic | 40.28M |